Open AccessAllergen‐specific immunotherapy for patients with atopic dermatitis sensitized to animal dander
Author(s) -
Chu Howard,
Park Kyung Hee,
Kim Su Min,
Lee JaeHyun,
Park JungWon,
Lee Kwang Hoon,
Park Chang Ook
Publication year - 2020
Publication title -
immunity, inflammation and disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 18
ISSN - 2050-4527
DOI - 10.1002/iid3.291
Subject(s) - dander , medicine , immunoglobulin e , house dust mite , atopic dermatitis , asthma , allergen , allergen immunotherapy , immunology , concomitant , desensitization (medicine) , allergy , immunotherapy , dermatology , antibody , immune system , receptor
Abstract Introduction Atopic dermatitis (AD) is a chronic inflammatory skin disease, and AD patients are commonly sensitized to house dust mite (HDM). Of the several treatment options available, allergen‐specific immunotherapy (AIT) has been recognized as an effective treatment modality that is directed toward the immunoglobulin E (IgE)‐mediated nature of AD, and subcutaneous administration using HDM is most commonly used for AIT in AD. For patients sensitized to animal (dog or cat) dander, the treatment may not be easy, especially when avoiding the allergen is not possible. Methods This study enrolled patients with AD who were sensitized to cat and/or dog dander and underwent AIT (n = 19). Patients’ medical information was obtained, including past treatment history, treatment duration of AIT, and the progress of treatment. Also, the specific IgE levels and IgG4 levels were measured before and after AIT. Results A total of 19 patients with AD underwent AIT using cat and/or dog dander. The patients consisted of 4 males and 15 females with an average age of 31.74 ± 9.71. Only two patients had AD only, and the other 17 patients had one or more concomitant allergic diseases, such as allergic rhinitis, allergic asthma, or allergic conjunctivitis. Seven patients were not sensitized to HDMs and only sensitized to cat and/or dog dander. The duration of AIT ranged from 2 to 58 months. The symptoms of 17 patients were well‐controlled, requiring only topical treatment and/or oral antihistamines. One patient required systemic cyclosporine, but only of low dose (25 mg/day). The specific IgE levels were decreased ( P = .005) and IgG4 levels showed the tendency of increasing after AIT. No adverse events were observed in these patients. Conclusion Although a larger number of patients for a longer follow‐up period are needed to precisely assess the treatment efficacy, AIT using cat and/or dog dander may be an effective treatment option for AD patients, especially for severe AD patients with other respiratory allergic comorbidities who cannot completely avoid the exposure to animal dander.